GOLDMAN SACHS GROUP INC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Back to NTLA Full portfolio

Position in NTLA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$20,874,049

+$7,788,035 QoQ

Shares Held

1,628,241

+11.9% QoQ

Ownership

1.17%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Derivatives in NTLA

reported options exposure · as of Jun 30, 2025

CallValue

$151,956

CallShares

16,200

PutValue

$151,956

PutShares

16,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. NTLA ranks #101 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,417,875	$1,079,677,898
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300,558	$1,004,863,129
3	MRNA	Moderna, Inc.	6,603,697	$335,467,805
4	ROIV	Roivant Sciences Ltd.	11,111,591	$307,791,069
5	PRAX	Praxis Precision Medicines, Inc.	710,734	$228,991,385
6	INCY	Incyte Corp	2,351,221	$221,296,919
7	RVMD	Revolution Medicines, Inc.	2,185,500	$212,539,874
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,965,432	$170,933,620

All Filings in NTLA

Export CSV

34 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$20,874,049	1,628,241	+11.9%	Shares	Defined	2026-05-15
2025-12-31	$13,086,014	1,455,619	-53.9%	Shares	Defined	2026-03-25
2025-12-31	$28,383,030	3,157,178	-26.2%	Shares	Sole	2026-02-12
2025-09-30	$73,892,751	4,278,677	+109.0%	Shares	Defined	2025-11-14
2025-06-30	$19,203,185	2,047,248	+12537.3%	Shares	Defined	2025-08-14
2025-06-30	$151,956	16,200	0.0%	Call	Defined	2025-08-14
2025-06-30	$151,956	16,200	0.0%	Put	Defined	2025-08-14
2025-03-31	$115,182	16,200	-99.3%	Put	Defined	2025-06-27
2025-03-31	$17,157,730	2,413,183	+14796.2%	Shares	Defined	2025-06-27
2025-03-31	$115,182	16,200	-99.2%	Call	Defined	2025-06-27
2024-12-31	$23,725,581	2,034,784	+96.7%	Shares	Defined	2025-02-11
2024-09-30	$21,258,584	1,034,481	-18.3%	Shares	Defined	2024-11-14
2024-06-30	$28,346,552	1,266,602	+18.7%	Shares	Defined	2024-08-13
2024-03-31	$29,365,824	1,067,460	+29.5%	Shares	Defined	2024-05-15
2023-12-31	$25,139,828	824,527	+3.5%	Shares	Defined	2024-05-14
2023-09-30	$25,177,835	796,263	-20.7%	Shares	Defined	2024-05-15
2023-06-30	$40,933,577	1,003,766	+16.8%	Shares	Defined	2024-05-14
2023-03-31	$32,032,893	859,482	+37.1%	Shares	Defined	2024-05-14
2022-12-31	$21,879,308	627,094	-36.1%	Shares	Defined	2024-05-14
2022-09-30	$54,939,009	981,755	+15.7%	Shares	Defined	2024-05-14
2022-06-30	$43,901,951	848,183	+59.7%	Shares	Defined	2024-05-14
2022-03-31	$38,588,932	531,016	-46.4%	Shares	Defined	2022-05-16
2021-12-31	$117,186,598	991,091	+6507.3%	Shares	Defined	2022-02-17
2021-12-31	$1,773,600	15,000	0.0%	Put	Defined	2022-02-17
2021-12-31	$1,773,600	15,000	-98.5%	Call	Defined	2022-02-17
2021-09-30	$130,164,402	970,290	-2.6%	Shares	Defined	2022-01-20
2021-06-30	$161,286,969	996,152	+2829.9%	Shares	Defined	2021-08-13
2021-06-30	$5,504,940	34,000	-95.7%	Call	Defined	2021-08-13
2021-03-31	$62,766,231	782,085	+19452.1%	Shares	Defined	2021-05-17
2021-03-31	$321,020	4,000	-99.6%	Call	Defined	2021-05-17
2020-12-31	$57,588,492	1,058,612	+96.0%	Shares	Defined	2021-02-12
2020-09-30	$10,737,028	540,092	+329.6%	Shares	Defined	2020-11-13
2020-06-30	$2,642,528	125,715	+35.2%	Shares	Defined	2020-08-12
2020-03-31	$1,136,851	92,956	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.